Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Announcement of fully underwritten rights issue
Contributed by:
PR Newswire
Tags
Oncoinvent-AS
More Like This
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue
Inside information: Preliminary result of Bioretec Oy's rights issue
Oncoinvent ASA announces oversubscribed private placement
Final results of Bioretec Ltd's successful rights issue
Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans
Sobi publishes the preliminary outcome of the rights issue
SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million
